Literature DB >> 29249812

Uncovering the mechanisms of Acinetobacter baumannii virulence.

Christian M Harding1,2, Seth W Hennon1, Mario F Feldman1,2.   

Abstract

Acinetobacter baumannii is a nosocomial pathogen that causes ventilator-associated as well as bloodstream infections in critically ill patients, and the spread of multidrug-resistant Acinetobacter strains is cause for concern. Much of the success of A. baumannii can be directly attributed to its plastic genome, which rapidly mutates when faced with adversity and stress. However, fundamental virulence mechanisms beyond canonical drug resistance were recently uncovered that enable A. baumannii and, to a limited extent, other medically relevant Acinetobacter species to successfully thrive in the health-care environment. In this Review, we explore the molecular features that promote environmental persistence, including desiccation resistance, biofilm formation and motility, and we discuss the most recently identified virulence factors, such as secretion systems, surface glycoconjugates and micronutrient acquisition systems that collectively enable these pathogens to successfully infect their hosts.

Entities:  

Mesh:

Year:  2017        PMID: 29249812      PMCID: PMC6571207          DOI: 10.1038/nrmicro.2017.148

Source DB:  PubMed          Journal:  Nat Rev Microbiol        ISSN: 1740-1526            Impact factor:   60.633


  127 in total

1.  Adherence of Acinetobacter baumannii strains to human bronchial epithelial cells.

Authors:  Je Chul Lee; Henk Koerten; Peterhans van den Broek; Henry Beekhuizen; Ron Wolterbeek; Maria van den Barselaar; Tanny van der Reijden; Joke van der Meer; Joke van de Gevel; Lenie Dijkshoorn
Journal:  Res Microbiol       Date:  2005-11-02       Impact factor: 3.992

2.  Acinetobacter baumannii response to host-mediated zinc limitation requires the transcriptional regulator Zur.

Authors:  Brittany L Mortensen; Subodh Rathi; Walter J Chazin; Eric P Skaar
Journal:  J Bacteriol       Date:  2014-05-09       Impact factor: 3.490

3.  Antimicrobial-Resistant Pathogens Associated With Healthcare-Associated Infections: Summary of Data Reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2011-2014.

Authors:  Lindsey M Weiner; Amy K Webb; Brandi Limbago; Margaret A Dudeck; Jean Patel; Alexander J Kallen; Jonathan R Edwards; Dawn M Sievert
Journal:  Infect Control Hosp Epidemiol       Date:  2016-08-30       Impact factor: 3.254

4.  A PmrB-Regulated Deacetylase Required for Lipid A Modification and Polymyxin Resistance in Acinetobacter baumannii.

Authors:  Chui-Yoke Chin; Kelsey A Gregg; Brooke A Napier; Robert K Ernst; David S Weiss
Journal:  Antimicrob Agents Chemother       Date:  2015-10-12       Impact factor: 5.191

5.  H-NS plays a role in expression of Acinetobacter baumannii virulence features.

Authors:  Bart A Eijkelkamp; Uwe H Stroeher; Karl A Hassan; Liam D H Elbourne; Ian T Paulsen; Melissa H Brown
Journal:  Infect Immun       Date:  2013-05-06       Impact factor: 3.441

6.  Multistate point-prevalence survey of health care-associated infections.

Authors:  Shelley S Magill; Jonathan R Edwards; Wendy Bamberg; Zintars G Beldavs; Ghinwa Dumyati; Marion A Kainer; Ruth Lynfield; Meghan Maloney; Laura McAllister-Hollod; Joelle Nadle; Susan M Ray; Deborah L Thompson; Lucy E Wilson; Scott K Fridkin
Journal:  N Engl J Med       Date:  2014-03-27       Impact factor: 91.245

7.  Growth of Acinetobacter baumannii in pellicle enhanced the expression of potential virulence factors.

Authors:  Sara Marti; Yassine Nait Chabane; Stéphane Alexandre; Laurent Coquet; Jordi Vila; Thierry Jouenne; Emmanuelle Dé
Journal:  PLoS One       Date:  2011-10-27       Impact factor: 3.240

8.  A novel method of consensus pan-chromosome assembly and large-scale comparative analysis reveal the highly flexible pan-genome of Acinetobacter baumannii.

Authors:  Agnes P Chan; Granger Sutton; Jessica DePew; Radha Krishnakumar; Yongwook Choi; Xiao-Zhe Huang; Erin Beck; Derek M Harkins; Maria Kim; Emil P Lesho; Mikeljon P Nikolich; Derrick E Fouts
Journal:  Genome Biol       Date:  2015-07-21       Impact factor: 13.583

9.  Joint Transcriptional Control of Virulence and Resistance to Antibiotic and Environmental Stress in Acinetobacter baumannii.

Authors:  Michael J Gebhardt; Larry A Gallagher; Rachael K Jacobson; Elena A Usacheva; Lance R Peterson; Daniel V Zurawski; Howard A Shuman
Journal:  MBio       Date:  2015-11-10       Impact factor: 7.867

10.  Medically Relevant Acinetobacter Species Require a Type II Secretion System and Specific Membrane-Associated Chaperones for the Export of Multiple Substrates and Full Virulence.

Authors:  Christian M Harding; Rachel L Kinsella; Lauren D Palmer; Eric P Skaar; Mario F Feldman
Journal:  PLoS Pathog       Date:  2016-01-14       Impact factor: 6.823

View more
  191 in total

1.  Intercellular Transfer of Chromosomal Antimicrobial Resistance Genes between Acinetobacter baumannii Strains Mediated by Prophages.

Authors:  Jun-Ichi Wachino; Wanchun Jin; Kouji Kimura; Yoshichika Arakawa
Journal:  Antimicrob Agents Chemother       Date:  2019-07-25       Impact factor: 5.191

2.  In Vitro Activity of Sulbactam-Durlobactam against Acinetobacter baumannii-calcoaceticus Complex Isolates Collected Globally in 2016 and 2017.

Authors:  Sarah M McLeod; Samir H Moussa; Meredith A Hackel; Alita A Miller
Journal:  Antimicrob Agents Chemother       Date:  2020-03-24       Impact factor: 5.191

3.  The apolipoprotein N-acyl transferase Lnt is dispensable for growth in Acinetobacter species.

Authors:  Celena M Gwin; Natalia Prakash; J Christian Belisario; Lubaina Haider; Marlene L Rosen; Luis R Martinez; Nathan W Rigel
Journal:  Microbiology       Date:  2018-10-11       Impact factor: 2.777

4.  Depletion of Alveolar Macrophages Increases Pulmonary Neutrophil Infiltration, Tissue Damage, and Sepsis in a Murine Model of Acinetobacter baumannii Pneumonia.

Authors:  Hiu Ham Lee; Lilit Aslanyan; Arjun Vidyasagar; Melissa B Brennan; Maxine S Tauber; Maria A Carrillo-Sepulveda; Michael R Dores; Nathan W Rigel; Luis R Martinez
Journal:  Infect Immun       Date:  2020-06-22       Impact factor: 3.441

5.  Contribution of Active Iron Uptake to Acinetobacter baumannii Pathogenicity.

Authors:  Federica Runci; Valentina Gentile; Emanuela Frangipani; Giordano Rampioni; Livia Leoni; Massimiliano Lucidi; Daniela Visaggio; Greg Harris; Wangxue Chen; Julia Stahl; Beate Averhoff; Paolo Visca
Journal:  Infect Immun       Date:  2019-03-25       Impact factor: 3.441

6.  L-lysine potentiates aminoglycosides against Acinetobacter baumannii via regulation of proton motive force and antibiotics uptake.

Authors:  Wanyan Deng; Tiwei Fu; Zhen Zhang; Xiao Jiang; Jianping Xie; Hang Sun; Peng Hu; Hong Ren; Peifu Zhou; Qi Liu; Quanxin Long
Journal:  Emerg Microbes Infect       Date:  2020-03-20       Impact factor: 7.163

7.  Optimization of 4-Substituted Benzenesulfonamide Scaffold To Reverse Acinetobacter baumannii Serum-Adaptive Efflux Associated Antibiotic Tolerance.

Authors:  Michaelle Chojnacki; Xufeng Cao; Mikaeel Young; Rebecca N Fritz; Paul M Dunman; Daniel P Flaherty
Journal:  ChemMedChem       Date:  2020-08-13       Impact factor: 3.466

8.  Deposition of Bacteria and Bacterial Spores by Bathroom Hot-Air Hand Dryers.

Authors:  Luz Del Carmen Huesca-Espitia; Jaber Aslanzadeh; Richard Feinn; Gabrielle Joseph; Thomas S Murray; Peter Setlow
Journal:  Appl Environ Microbiol       Date:  2018-04-02       Impact factor: 4.792

9.  Histidine Utilization Is a Critical Determinant of Acinetobacter Pathogenesis.

Authors:  Zachery R Lonergan; Lauren D Palmer; Eric P Skaar
Journal:  Infect Immun       Date:  2020-06-22       Impact factor: 3.441

10.  Pan-transcriptomic analysis identified common differentially expressed genes of Acinetobacter baumannii in response to polymyxin treatments.

Authors:  Mengyao Li; Su Mon Aye; Maizbha Uddin Ahmed; Mei-Ling Han; Chen Li; Jiangning Song; John D Boyce; David R Powell; Mohammad A K Azad; Tony Velkov; Yan Zhu; Jian Li
Journal:  Mol Omics       Date:  2020-05-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.